Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent-Reference-Cited by-同舟云学术

Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent

Published:2004-11 Issue:5 Volume:61 Page:899-903
ISSN:0969-8043
Container-title:Applied Radiation and Isotopes
language:en
Short-container-title:Applied Radiation and Isotopes

Author:

Barth Rolf F,Wu Gong,Yang Weilian,Binns Peter J,Riley Kent J,Patel Hemant,Coderre Jeffrey A,Tjarks Werner,Bandyopadhyaya A.K,Thirumamagal B.T.S,Ciesielski Michael J,Fenstermaker Robert A

Publisher

Elsevier BV

Subject

Radiation

Reference9 articles.

1. Determination of boron in tissues and cells using direct-current plasma atomic emission spectroscopy;Barth;Anal. Chem.,1991

2. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas;Barth;Cancer Res.,2002

3. Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors;Barth;Int. J. Radiat. Oncol. Biol. Phys.,2004

4. Targeting the epidermal growth factor receptor for cancer therapy;Mendelsohn;J. Clin. Oncol.,2002

5. Mixed field dosimetry of epithermal neutron beams for boron neutron capture therapy at the MITR-II research reactor;Rogus;Med. Phys.,1994

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The current status and future perspectives of clinical boron neutron capture therapy trials;Health and Technology;2024-04-20

2. Nanostructured boron agents for boron neutron capture therapy: a review of recent patents;Medical Review;2023-09-15

3. Dendritic Structures Functionalized with Boron Clusters, in Particular Carboranes, and Their Biological Properties;Pharmaceutics;2023-08-10

4. Animal Tumor Models for Boron Neutron Capture Therapy Studies (Excluding Central Nervous System Solid Tumors);Cancer Biotherapy and Radiopharmaceuticals;2022-09-21

5. Surface Engineered Dendrimers: A Potential Nanocarrier for the Effective Management of Glioblastoma Multiforme;Current Drug Metabolism;2022-08